Immune-mediated diseases including hemolytic anemia and thrombocytopenia are serious welfare-impacting conditions in dogs requiring complex long-term management.
Dogs with immune-mediated disease experience acute welfare crises from the disease itself and chronic welfare impacts from long-term immunosuppressive management. The medications needed to control these conditions cause substantial side effects that reduce quality of life. Relapse risk creates ongoing owner anxiety and repeated treatment episodes. Specialist veterinary care including internal medicine specialists and blood transfusion availability significantly improves survival outcomes. Quality of life monitoring throughout treatment is essential for informed decision-making.